Haemonetics (HAE) Tops Q3 EPS by 10c; raises guidance
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $108.46 +0.22%
Financial Fact:
Research, development and engineering: 8.34M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Research, development and engineering: 8.34M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Haemonetics (NYSE: HAE) reported Q3 EPS of $1.04, $0.10 better than the analyst estimate of $0.94. Revenue for the quarter came in at $336 million versus the consensus estimate of $320.77 million.
GUIDANCE:
Haemonetics sees FY2024 EPS of $3.90-$4.00, versus the consensus of $3.89.
For earnings history and earnings-related data on Haemonetics (HAE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
- Haemonetics (HAE) PT Raised to $119 at Baird
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
